Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | CFB | P00751 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23049672 | 0.91 | DRD2 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL25800782 | 0.91 | DRD2 (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL21988581 | 0.90 | P2RX7 (0.47) | P2RX7CFBALDH1A1NR1H2NR1H3 | |
| SCHEMBL24427032 | 0.90 | P2RX7 (0.41) | P2RX7CFBDRD2 | |
| SCHEMBL23158394 | 0.86 | CARM1 (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL24427035 | 0.84 | CHRM2 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL24405088 | 0.83 | ALDH1A1 (0.47) | P2RX7CFBALDH1A1DRD2 | |
| SCHEMBL21500120 | 0.83 | CFB (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3609864 | 0.78 | CHRNB2 (0.50) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL22562919 | 0.76 | ALDH1A1 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3809506-B1 | LITHIUM ION BATTERY AND DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-12-13 | — | — | EP | disclosed |
| EP-3514882-B1 | ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-12-13 | — | — | EP | disclosed |
| EP-3787089-B1 | LITHIUM-ION BATTERY AND APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-11-22 | — | — | EP | disclosed |
| EP-3796449-B1 | LITHIUM-ION BATTERY AND DEVICE COMPRISING THE SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-11-15 | — | — | EP | disclosed |
| EP-3799183-B1 | LITHIUM-ION BATTERY AND DEVICE COMPRISING THE SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-11-01 | — | — | EP | disclosed |
| EP-3809507-B1 | LITHIUM-ION BATTERY AND DEVICE COMPRISING THE SAME | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-10-11 | — | — | EP | disclosed |
| US-11695157-B2 | Lithium-ion battery and apparatus | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2023-07-04 | — | — | US | disclosed |
| US-20220393236-A1 | LITHIUM-ION BATTERY AND APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2022-12-08 | — | — | US | disclosed |
| US-20220209296-A1 | LITHIUM-ION BATTERY AND APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2022-06-30 | — | — | US | disclosed |
| EP-3783723-B1 | LITHIUM-ION BATTERY AND APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2022-05-18 | — | — | EP | disclosed |
| US-20190326635-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2019-10-24 | — | — | US | disclosed |
| EP-3557683-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2019-10-23 | — | — | EP | disclosed |
| EP-3557682-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2019-10-23 | — | — | EP | disclosed |
| EP-3557678-A1 | ELECTROLYTE AND BATTERY | Contemporary Amperex Technology Co., Limited (CN) | 2019-10-23 | — | — | EP | disclosed |
| EP-3557681-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2019-10-23 | — | — | EP | disclosed |
| US-20190267670-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2019-08-29 | — | — | US | disclosed |
| EP-3514882-A1 | ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2019-07-24 | — | — | EP | disclosed |
| EP-3514879-A1 | ELECTROLYTE SOLUTION AND BATTERY | Contemporary Amperex Technology Co., Limited (CN) | 2019-07-24 | — | — | EP | disclosed |
| EP-3514881-A1 | ELECTROLYTE AND ELECTROCHEMICAL APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2019-07-24 | — | — | EP | disclosed |
| EP-3514880-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2019-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220209296-A1 | LITHIUM-ION BATTERY AND APPARATUS | CACNA1D, CACNB1, CACNA1S | CHRM2 630/4885CHRM4 1556/4885CHRM5 2081/4885 |
| US-11695157-B2 | Lithium-ion battery and apparatus | KCNN4, CACNB1, CACNA1B | CHRM2 770/4885CHRM4 699/4885CHRM5 1499/4885 |
| US-20220393236-A1 | LITHIUM-ION BATTERY AND APPARATUS | CACNB1, LMNB1, KCNN4 | CHRM2 646/4885CHRM4 853/4885CHRM5 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.